Antistreptolysin O determination kit as well as preparation method and application thereof
By using EDC to activate the coupling method of carboxylated latex microspheres with SDS and pentaerythritol in the anti-streptolysin O assay kit, combined with ethanolamine and gelatin blocking agent, the aggregation problem during the coupling process of antigen and microspheres was solved. , improves the stability and sensitivity of the reagent, reduces chylo interference, and is suitable for detection of fully automatic biochemical analyzer.
Patent Information
- Application Number
- CN202411131814.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-08
AI Technical Summary
The existing anti-streptolysin O assay kits are prone to agglomeration during the coupling of antigens and microspheres, and the operation is complicated, the uniformity and stability of the reagent are difficult to control, and the components such as bilirubin, hemoglobin and chylo are in the serum. It interferes with the detection results, resulting in low sensitivity.
The antigen is activated by chemical coupling method through water-soluble carbodiimide (EDC), and the carboxylated latex microspheres are covalently bound to the amino group to prevent agglomeration. SDS and pentaerythritol are added to the reagent to maintain the microspheres. The surface electrostatic repulsion, combined with ethanolamine and gelatin as sealing agents, improves the steric conformational stability of the antigen, and uses sodium alginate and DTPA to reduce the interference of chylomicrons.
The anti-streptococcus hemolysin O assay kit has strong stability, high sensitivity, good linearity, simple operation, reduced coupling time, improved reagent uniformity and anti-interference ability, and is suitable for detection of fully automatic biochemical analyzer. .
Smart Images

Figure CN118914542A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biochemical reagent determination, in particular to an anti-streptolysin O determination kit, and also to a preparation method and application of the anti-streptolysin O determination kit. Background Art
[0002] Streptolysin O (SLO) is a protein containing -SH groups expressed by various hemolytic streptococci. It is easily oxidized to form -SS groups and temporarily loses its hemolytic ability. It can be revitalized and regain its hemolytic effect with the help of reducing agents. The hemolytic toxin "O" can dissolve red blood cells, has strong antigenicity, and is toxic to various cells in the body. After the human body is infected with group A hemolytic streptococci, "O" hemolysin exists in the body as an antigenic substance, causing the human body to produce SLO-specific antibodies, and a large amount of anti-streptolysin O antibodies appear in the serum.
[0003] Anti-Streptolysin O (ASO) is also called anti-streptolysin "O" (ASO). Anti-streptolysin "O" can be detected in people within a few months after being infected with hemolytic streptococci. The ASO antibody in the serum binds to the hemolytic toxin "O" and does not cause hemolysis. If the corresponding antibody is present in the serum being tested, it means that the body has been infected with hemolytic streptococci. Therefore, ASO determination is very valuable for diagnosing streptococcal infection, and its presence and content can reflect the severity of the infection.
[0004] The normal value of ASO in healthy adults varies depending on the region, age, season, climate, and prevalence of streptococci, and is generally not higher than 200 IU / ml. ASO levels are significantly elevated when testing for rheumatic fever, scarlet fever, erythema nodosum, acute glomerulonephritis, acute tonsillitis, etc. In addition, the ASO content in a small number of patients with tuberculosis, hepatitis, connective tissue diseases, and multiple myeloma will also increase. Therefore, the titer of anti-streptococcal hemolytic toxin "O" antibodies can assist in the diagnosis of diseases caused by streptococcal reactions such as rheumatic fever and acute glomerulonephritis.
[0005] At present, latex agglutination method, hemolysis inhibition method, enzyme-linked immunosorbent assay, immunoturbidimetry and other detection methods can be used for the detection of anti-streptolysin O. Among the above detection methods, latex immunoturbidimetry has the advantages of simple operation, strong specificity, low cost, and can take into account both detection sensitivity and linear range. It also has the advantages of small sample volume and can be used to measure a small amount of samples and emergency samples. The detection principle is to use chemical coupling method to bind antigens to latex particles, and to react with antibodies in the corresponding specimens to form a network structure. After light passes through, the intensity of transmitted light and scattered light changes more significantly. The turbidity generated by the aggregates is measured at a specific wavelength to obtain the content of the test substance in the sample.
[0006] At present, the immunoturbidimetric method for the determination of anti-streptococcal hemolysin "O" on the market includes reagent 1 and reagent 2; reagent 1 is a reagent buffer, and reagent 2 is a latex microsphere-coated antigen reagent; this part is to covalently bind the antigen to the latex particles by chemical coupling, but in the actual operation process, the activated microspheres will aggregate and precipitate after mixing with the SLO antigen. In order to solve the problem of this step, ultrasonic treatment, centrifugation and resuspension are often used in reagent coupling, which is cumbersome, takes a long time to prepare, and the uniformity and stability of the reagents are difficult to control. In addition, components such as bilirubin, hemoglobin and chyle in serum have a greater impact on the ASO kit, and the kit has poor anti-interference ability, so the detection sensitivity is low. Summary of the invention In order to solve the above problems, the present invention provides an ASO determination kit and a preparation method and application thereof. The kit is a liquid kit with strong stability, high sensitivity, good linearity and low cost.
[0008] The technical scheme of the present invention is as follows: firstly, the microspheres are mixed with a labeling buffer solution, and then the antigen is added to the mixed solution, and a chemical method is used for coupling. The carboxylated latex microspheres are activated by water-soluble carbodiimide (EDC) to covalently bind with hemolysin "O" in the form of carboxyl and amino groups, and the surface electrostatic repulsion of the microspheres after activation is maintained to prevent the occurrence of agglomeration. The antigen is coated on the latex microspheres to obtain a latex reagent, and an anti-streptococcal hemolysin "O" detection kit is prepared. This test kit includes reagents R1 and R2, and the specific components are as follows: Reagent R1 contains the following ingredients: Tris buffer 10-100mmol / L; Sensitizer 10-20g / L; NaCl 9-15 g / L; Surfactants Sodium alginate 0.01%-2%; DTPA 0.01%-2%; Preservative 0.5-1 ml / L; Reagent R2 contains the following ingredients: Mixing buffer: Labeling buffer 10-100mmol / L; Storage buffer 20-100mmol / L; SDS 0.1-0.25 g / L; Pentaerythritol 0.1-0.25g / L; SLO antigen coated latex microspheres 10-50 mg / L; Protective agent 10-25g / L; Sealing agent 1.5-40ml / L; Surfactant 0.01%-2%; Preservative 0.5-1ml / L; The percentages mentioned are by volume. Preferably, the pH of the reagent R1 is 7.0-7.4.
[0009] Preferably, the pH of the reagent R2 is 6.8-7.4.
[0010] Preferably, the labeling buffer is any one of glycine buffer, phosphate buffer, MES buffer, Tris-HCl buffer, Hepes buffer, MOPS buffer, and DIPSO buffer, more preferably phosphate buffer.
[0011] Preferably, in the reagent R1, the sensitizer is any one of PEG2000, PEG4000, PEG6000, PEG8000, and PEG10000, more preferably PEG4000.
[0012] Preferably, in the reagent R1, the inorganic salt is any one of KCl, CaCl2, NaCl, BaCl2, MgCl2, and AlCl3, more preferably NaCl.
[0013] Preferably, the surfactant in reagents R1 and R2 is selected from at least one of Tween-20, Span-20, Triton X-100, TX-10, OP-10, ON-870, F68, Brij35, hexadecyl ammonium chloride, sodium alginate, glycerol, and DTPA (dimethyltriaminepentaacetic acid). The surfactant in reagent R1 is more preferably sodium alginate and DTPA, and the surfactant in reagent R2 is more preferably Tween-20.
[0014] Preferably, the blocking agent in reagent R2 is selected from at least one of BSA, gelatin, ethanolamine, serum, glycine, and skimmed milk powder, more preferably ethanolamine or gelatin.
[0015] Preferably, the protective agent in reagent R2 is selected from at least one of BSA, sucrose, lactose, trehalose and mannitol, more preferably trehalose.
[0016] Preferably, the preservative in R1 and R2 is any one of sodium azide, gentamicin, thimerosal, Proclin300, and isothiazolinone, more preferably Proclin300.
[0017] In reagent R2, the antigen SLO is a recombinant protein, and the average particle size of the SLO antigen-coated latex microspheres is 140 nm.
[0018] The method for using the assay kit includes the following steps: after the serum sample is mixed and incubated with reagent R1, R2 is added and mixed and incubated for 20 seconds, the absorbance value is detected at a main wavelength of 546nm and a secondary wavelength of 800, and after 5 minutes, the absorbance value is detected again to obtain the absorbance value, and the ASO content is calculated using the serum standard data.
[0019] Beneficial effects of the present invention 1) The stable antistreptolysin O assay kit of the present invention is a liquid double reagent, which does not need to be reconstituted and can be used directly after opening the bottle.
[0020] 2) The anti-streptolysin O assay kit and the detection method thereof of the present invention adopt latex immunoturbidimetry, and avoid the phenomenon of antibody precipitation by adding raw materials and changing the order of adding raw materials during coupling. Specifically, the microspheres are preferentially mixed and incubated with a coupling buffer containing 0.015% SDS and 0.01% pentaerythritol and the SLO antigen, and the antigen is coated on the surface of the microspheres by activating the carboxyl group through EDC. The SDS and pentaerythritol in the buffer synergistically maintain the surface electrostatic repulsion of the activated microspheres, avoiding the occurrence of coagulation and agglomeration. The coupling scheme does not require ultrasonic, centrifugal and resuspension treatments, and a stable latex reagent can be obtained. The operation is simple, the coupling time is reduced, the sensitivity of the reagent is improved, the uniformity and stability of the reagent are guaranteed, and it can be applied to various types of fully automatic biochemical analyzers for analysis.
[0021] 3) The kit of the present invention specifically adds composite blocking agents ethanolamine and gelatin to better bind to the carboxyl sites of unbound antigens on the activated microspheres. The small molecules and macromolecules coordinate with each other to block the redundant sites, which can effectively reduce the steric hindrance of antigen-antibody binding, facilitate the exposure of antigenic determinants, ensure the stability of the antigen's spatial conformation, reduce the impact of blocking on the binding epitope, and improve the sensitivity of the reagent; the chelating effect and interfacial activity of the surfactant sodium alginate and DTPA can form polymers with chylomicrons and disperse and mask chylomicrons, avoiding nonspecific reactions caused by excessive polymers. The synergistic effect of the composite blocking agent and the surfactant improves the anti-interference ability and effectively improves the sensitivity, stability and specificity of the kit; 4) The kit of the present invention can detect the content of antistreptolysin O in the blood on a fully automatic biochemical analyzer with a wavelength of 400-800nm. It can be used directly on the machine, is fast and accurate, has a high degree of automation, and greatly improves work efficiency. In addition, the amount of sample to be tested is small, and a small amount of samples and emergency samples can be measured. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 It is a correlation curve of the accuracy comparison of the reagent in Example 1 and the reagent in Comparative Example 1; Figure 2is the linear correlation curve of the reagent in Example 1; Figure 3 The concentration changes of the anti-streptolysin O assay reagents provided in Example 1 and Comparative Examples 1, 8, 9, and 10 were subjected to stability tests. DETAILED DESCRIPTION
[0023] The present invention will be further described below in conjunction with specific embodiments: When the kit described in this embodiment is used, its determination method is to use the Mindray 800 fully automatic biochemical analyzer with a dual reagent function, and to perform the determination using the endpoint method, with the main detection wavelength being 546 nm, and the operation is as follows: Add 3µL of sample or calibrator, then add 240µL of R1 reagent, pre-incubate for 5 minutes, then add 60µL of R2 reagent, mix well, delay for 1 minute, read the absorbance A1, and read the absorbance A2 after 5 minutes.
[0024] Calculate ∆A=(A2-A1).
[0025] Antistreptolysin O content (mg / L) = (ΔA sample ÷ ΔA calibrator) × calibrator concentration.
[0026] Sample requirements: 1. Fresh serum.
[0027] 2. Sample stability: The specimen can be stable for 3 days if stored at 2~8℃ and can be stable for 2 weeks if stored at -20℃.
[0028] Example 1 A conventional anti-streptolysin "O" detection kit comprises two liquid reagents (reagent R1 and reagent R2). Reagent R1 is a reaction buffer and reagent R2 is a solution containing SLO latex microspheres.
[0029] Reagent R1 contains the following ingredients: Tris buffer 50mmol / L; Sensitizer (PEG4000) 10g / L; NaCl 9g / L; Sodium alginate 0.05%; DTPA 0.1%; Proclin300 0.5ml / L; The pH value of reagent R1 is 7.2.
[0030] Reagent R2 contains the following ingredients: Phosphate buffer 10mmol / L; Boric acid buffer 25mmol / L; SDS 0.1 g / L; Pentaerythritol 0.15 g / L; SLO antigen coated latex microspheres 42 mg / L; Trehalose 25g / L; Gelatin 1ml / L; Ethanolamine 0.5ml / L; Tween-20 0.16%; Proclin300 0.5ml / L; The pH value of reagent R2 is 7.2.
[0031] The percentages mentioned are by volume.
[0032] The preparation method of the kit is as follows: 1. Solution preparation Labeling buffer: phosphate buffer, dissolve 16 g sodium chloride, 0.41 g potassium chloride, 7.266 g disodium hydrogen phosphate dodecahydrate and 0.39 g potassium dihydrogen phosphate in 800 ml deionized water, adjust the pH to 7.15, add 0.015% SDS and 0.01% pentaerythritol, make up to 1 L with deionized water, and store at 4°C for later use.
[0033] Storage buffer: boric acid buffer, take 800 ml of deionized water to dissolve 20.578 g of borax and 159.597 g of boric acid, mix thoroughly, add 55.26 g of trehalose, adjust the pH to 8.0, make up to 1 L with deionized water, add preservative Proclin 300, and store at 4°C for later use.
[0034] EDC activation buffer: Take 7.5 mg of EDC and dissolve it in 10 ml of labeling buffer to make 7.5 mg / ml EDC activation buffer (prepare and use immediately).
[0035] Blocking reagent: Weigh 5g of gelatin powder, add 40ml of double distilled water, soak for 10 minutes, heat and stir in a hot water bath until completely dissolved (the temperature should not exceed 70℃), let stand at room temperature, weigh 2ml of ethanolamine, add to the solution and stir until completely dissolved, and make up to 50ml. This reagent is the blocking reagent. Surfactant reagent: Take 4 ml of Tween 20 and add it to 6 ml of ultrapure water and mix thoroughly. The reagent is a surfactant.
[0036] Protective agent: Preparation of R1 buffer (reagent R1): Prepare 0.5M Tris buffer, pH 7.2, containing 0.9% NaCl, 1% (w / v) PEG4000, 0.05% (w / v) sodium alginate, 1% (w / v) DTPA, 0.05% (w / v) Proclin-300, and store at 4°C for future use. 2. Latex microspheres labeled protein Take 1 ml of carboxylated polystyrene latex with a concentration of 5% and an average particle size of 140 nm and dissolve it in 7 ml of labeling buffer and shake it in a constant temperature water bath at 37°C for 10 minutes; add 1.25 mg of SLO antigen to the fully mixed microsphere solution and shake it in a constant temperature water bath at 37°C for 30 minutes; add 100 ul of EDC activation buffer with a concentration of 7.5 mg / ml and shake it in a constant temperature water bath at 37°C for 90 minutes; After adding 30ul of blocking agent, shake in a constant temperature water bath at 37°C for 20min; after adding 120ul of surfactant, 21ml of boric acid buffer and preservative Proclin 300, shake in a constant temperature water bath at 37°C for 30min; obtain SLO protein labeled latex microsphere solution, which is reagent R2.
[0037] 3. Preparation of latex test kit The above prepared solution is packaged in plastic bottles with the specifications of reagent R1: 40 ml, reagent R2: 10 ml, which is the anti-streptolysin "O" latex immunoturbidimetric detection kit (ASO latex kit).
[0038] Comparative Example 1 Commercially available imported antistreptolysin "O" test kit.
[0039] Comparative Example 2 The only difference from the anti-streptolysin "O" detection kit in Example 1 is that reagent R1 does not contain sodium alginate and DTPA, and the rest is the same as Example 1.
[0040] Comparative Example 3 The difference from the anti-streptolysin "O" detection kit in Example 1 is that the reagent R1 does not contain sodium alginate, and the rest is the same as Example 1.
[0041] Comparative Example 4 The difference from the anti-streptolysin "O" detection kit in Example 1 is that reagent R1 does not contain DTPA, and the rest is the same as Example 1.
[0042] Comparative Example 5 The difference from the anti-streptolysin "O" detection kit in Example 1 is only that the reagent R2 and the labeling buffer do not contain SDS and pentaerythritol, and the rest are the same as Example 1.
[0043] Comparative Example 6 The difference from the anti-streptolysin "O" detection kit in Example 1 is only that the reagent R2 and the labeling buffer do not contain pentaerythritol, and the rest is the same as Example 1.
[0044] Comparative Example 7 The difference from the anti-streptolysin "O" detection kit in Example 1 is only in reagent R2, and the labeling buffer does not contain SDS, and the rest is the same as Example 1.
[0045] Comparative Example 8 The only difference from the anti-streptolysin "O" detection kit in Example 1 is that the reagent R2 does not contain gelatin and ethanolamine, but is replaced with BSA of the same quality. The rest is the same as in Example 1.
[0046] Comparative Example 9 The difference from the anti-streptolysin "O" detection kit in Example 1 is that the reagent R2 does not contain gelatin, and the rest is the same as Example 1.
[0047] Comparative Example 10 The difference from the anti-streptolysin "O" detection kit in Example 1 is that reagent R2 does not contain ethanolamine, and the rest is the same as Example 1.
[0048] Performance Verification Test 1 Accuracy comparison test: 20 clinical serum samples were tested with the reagents of Example 1 and Comparative Example 1 at the same time, and the test results were analyzed for correlation, and the correlation coefficient r was calculated; the test results of the reagents of Comparative Example 1 were used as the control value, and the relative deviations of the 20 pairs of data were calculated respectively. It is required that r is not less than 0.99, and the relative deviation does not exceed ±10%. The test results are shown in Table 1, and the correlation curves of the reagents of Example 1 and Comparative Example 1 were obtained (see Table 1). Figure 1 as shown).
[0049] Table 1 Accuracy correlation comparison test results Table 2 Correlation coefficients of the reagents in comparative example 1 and the reagents in example 1 From Table 1 and Figure 1 It can be seen that the maximum deviation of the test kit serum test of the reagents in Example 1 and Comparative Example 1 is 7.92%, the correlation coefficient of the two reagents is greater than 0.99, and the test results of the reagents in Example 1 and Comparative Example 1 are very close. Therefore, the reagent in Example 1 provided by the present invention has a good correlation with the imported reagents and can completely replace the imported reagents to meet clinical needs.
[0050] Test 2 Linearity experiment: Take the high-value sample of anti-streptolysin O as 634 IU / mL, dilute it, prepare 5 samples of different concentrations, namely 634 IU / mL, 317 IU / mL, 158 IU / mL, 79 IU / mL, and 0 IU / mL, and use the reagent of Example 1 for detection. Each sample at each concentration level is measured 3 times, and the average value is taken. The detection results are shown in the table.
[0051] Table 3 Linearity test results From Table 3 and Figure 2 It can be seen that Example 1 of the present invention changes linearly with the dilution concentration, and the linear correlation coefficient reaches 0.9997, which meets the standard requirements. This shows that the linear range of Example 1 is good. The linear range of Example 1 can replace the imported reagents. The better linear change of the reagent in Example 1 can better meet the requirements of clinical case samples.
[0052] Test 3 Interference experiment: Take the quality control material with traceability, the median quality control material (target value 300.0±30.0IU / mL), and add the chylomicron content in the table. Then use the reagent of Example 1, the reagent of Comparative Example 1, the reagent of Comparative Example 2, the reagent of Comparative Example 3, and the reagent of Comparative Example 4 to detect the content of antistreptolysin O in the sample at the same time, measure 5 times respectively, and calculate the average value. The test results of each group are shown in Table 3.
[0053] Table 3 Reagent anti-interference test results As can be seen from Table 3, when the chylomicron concentration increases, the reagents in Example 1 are not significantly disturbed, the reagents in Comparative Example 1 are slightly disturbed, and the reagents in Comparative Example 2, Comparative Example 3, and Comparative Example 4 are significantly disturbed. Compared with the reagents in Comparative Example 3 and Comparative Example 4, the reagent in Example 1 containing two components has a stronger anti-interference ability. This shows that after adding sodium alginate and DTPA components, the synergistic effect of the two significantly improves the anti-interference performance of the reagent in Example 1, which is better than the reagent in Comparative Example 1 and meets clinical requirements.
[0054] Test 4 Sensitivity experiment: Take the quality control material with traceability and the low value quality control material (target value 100.0±10.0IU / mL), and then use the reagent of Example 1, the reagent of Comparative Example 1, the reagent of Comparative Example 2, and the reagent of Comparative Example 3 to detect the content of antistreptolysin O in the sample at the same time, measure 5 times respectively to calculate the average reactivity, and the test results of each group are shown in Table 4.
[0055] Table 4 Reagent sensitivity test results As can be seen from Table 4, when testing low-value quality control, the reagent in Example 1 has the highest reactivity, indicating that the reagent has the highest sensitivity in detecting low values, is more accurate in detection, and is superior to the reagent in Comparative Example 1. The reagent in Comparative Example 5 does not add SDS and pentaerythritol, and the reagent reactivity is the lowest. The reagent in Comparative Example 6 adds pentaerythritol, and the reagent reactivity rebounds. The reagent in Comparative Example 7 adds SDS reagent, and the reagent reactivity rebounds. The synergistic use of low-concentration SDS and pentaerythritol can improve the reactivity of the reagent and enhance the sensitivity of the reagent. This is mainly because during the reagent coupling process, the synergistic use of SDS and pentaerythritol ensures that the antibody does not precipitate during the chemical binding process with the microspheres, thereby improving the effective utilization rate of the antibody, thereby improving the sensitivity of the reagent, making the reagent in Example 1 superior to the reagent in Comparative Example 1. Test 5 Stability test: The stability test of the anti-streptolysin O assay reagent provided by the reagent of Example 1 and the reagent of Comparative Example 1, the reagent of Comparative Example 8, the reagent of Comparative Example 9, and the reagent of Comparative Example 10 was performed. The reagents of Example 1 and Comparative Example 1, the reagent of Comparative Example 8, the reagent of Comparative Example 9, and the reagent of Comparative Example 10 were stored together in a 37°C oven, and the quality control product with a detection target value of 300±30 mg / L was tested once every 24 hours, and each group was tested 5 times, the average value was calculated, and the changes in the measurement values of the quality control product were monitored. The test results are shown in Table 5.
[0056] Table 5 Reagent stability test results From Table 5 and Figure 3 It can be seen that the reagent of Example 1 provided by the present invention has basically no change in the accelerated experiment within 7 days, and has good stability; the reagent of Comparative Example 1 has a certain degree of decrease in detection value, but is still within the quality control detection range; the detection of the reagents of Comparative Examples 8, 9, and 10 has all declined significantly. The stability of the reagent of Example 1 is better than that of the reagents of Comparative Examples 1, 8, 9, and 10. It shows that the combined use of ethanolamine and gelatin sealant of the present invention can significantly improve the stability of the anti-streptolysin O assay kit.
[0057] In summary, the kit adds sodium alginate and DTPA to better reduce the interference of chylomicrons and avoid nonspecific reactions caused by excessive polymers; SDS and pentaerythritol avoid the occurrence of coagulation and agglomeration, are easy to operate, reduce coupling time, can improve the analytical sensitivity of the reagent, and ensure the uniformity and stability of the reagent; the coordinated use of ethanolamine and gelatin blocks redundant sites, ensures the stability of the antigen spatial conformation, reduces the influence of the blockade on the binding epitope, and enhances the stability of the kit; therefore, the kit is a liquid kit with strong stability, high sensitivity, good anti-interference and low cost. It provides a good development space for the kit of the present invention and enhances the competitiveness of the kit of the present invention in the market.
[0058] The specific embodiments described herein are merely examples of the spirit of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in similar ways, but they will not deviate from the spirit of the present invention or exceed the scope defined by the appended claims.
[0059] Although the present invention has been described in detail and some specific embodiments have been cited, it is obvious to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the present invention.
Claims
1. A kit for determining antistreptolysin O, comprising reagents R1 and R2, characterized in that: Reagent R1 contains the following ingredients: Buffer 10-100mmol / L; Sensitizer 10-20g / L; Inorganic salt 9-15g / L; Surfactant 0.01%-2%; Preservative 0.5-1 ml / L; Reagent R2 contains the following ingredients: Mixing buffer: Labeling buffer 10-100mmol / L; Storage buffer 20-100mmol / L; SDS 0.1-0.25 g / L; Pentaerythritol 0.1-0.25g / L; SLO antigen coated latex microspheres 10-50 mg / L; Protective agent 10-25g / L; Sealing agent 1.5-40ml / L Surfactant 0.01%-2%; Preservative 0.5-1ml / L; The percentages mentioned are by volume.
2. The antistreptolysin O assay kit according to claim 1, characterized in that: The pH of reagent R1 is 7.0-7.4; the pH of reagent R2 is 6.8-7.
4.
3. An antistreptolysin O assay kit according to claim 1, characterized in that: The labeling buffer is any one of glycine buffer, phosphate buffer, MES buffer, Tris-HCl buffer, Hepes buffer, MOPS buffer, and DIPSO buffer, more preferably phosphate buffer; The sensitizer is any one of PEG2000, PEG4000, PEG6000, PEG8000, and PEG10000, more preferably PEG4000; The inorganic salt is any one of KCl, CaCl2, NaCl, BaCl2, MgCl2, and AlCl3; more preferably NaCl.
4. The antistreptolysin O assay kit according to claim 1, characterized in that: The surfactant in reagents R1 and R2 is selected from at least one of Tween-20, Span-20, Triton X-100, TX-10, OP-10, ON-870, F68, Brij35, hexadecyl ammonium chloride, sodium alginate, glycerol, and DTPA; the surfactant in reagent R1 is more preferably sodium alginate and DTPA, and the surfactant in reagent R2 is more preferably Tween-20.
5. The antistreptolysin O assay kit according to claim 1, characterized in that: The blocking agent in reagent R2 is selected from at least one of BSA, gelatin, ethanolamine, serum, glycine, and skimmed milk powder, more preferably ethanolamine and gelatin; The protective agent in reagent R2 is selected from at least one of BSA, sucrose, lactose, trehalose and mannitol, more preferably trehalose; The preservative in R1 and R2 is any one of sodium azide, gentamicin, thimerosal, Proclin300, and isothiazolinone, more preferably Proclin300.
6. The anti-streptolysin O assay kit according to claim 1, characterized in that: The average particle size of SLO antigen-coated latex microspheres was 140 nm.
7. A method for preparing the antistreptolysin O assay kit according to any one of claims 1 to 6, characterized in that: First, streptolysin O-coated latex microspheres were prepared. The preparation method was as follows: 1 ml of surface carboxylated polystyrene latex microspheres were taken. Dissolve in 7 ml labeling buffer and mix thoroughly, add 1.25 mg of SLO antigen and mix for 30 minutes, then add the water-soluble carbodiimide activated carboxylated latex microspheres, apply chemical coupling, and covalently bind to hemolysin "O" in the form of carboxyl and amino groups, mix and stir at 37°C for 1.5 hours to couple the microspheres and antigen; add 30 ul of blocking agent and shake in a constant temperature water bath at 37°C for 20 minutes; add 120 ul of surfactant and 21 ml of boric acid buffer and preservative and shake in a constant temperature water bath at 37°C for 30 minutes; obtain SLO protein labeled latex microsphere solution, which is reagent R2; then add other substances according to the proportion to dissolve to reagent R1 to prepare the anti-streptococcal hemolysin O assay kit.
